idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Scientists from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany have succeeded in generating a hyperactive "jumping gene" (a transposon) and hope to have an improved tool for basic research and gene therapy. "The new transposon system is able to introduce genes into cells and to stably insert them into the cell's genome at an unprecedented efficiency," Dr. Lajos Mátés, Dr. Zoltán Ivics and Dr. Zsuzsanna Izsvák point out. They worked together with scientists from the Catholic University of Leuven, Belgium (Nature Genetics, doi: 10.1038/ng.343).*
Transposable elements are molecular parasites that propagate themselves in genomes. But at the same time they provide plasticity to the genome that clearly contributed to the evolution of gene function across the tree of life. About half of the human genome is derived from ancient transposable element sequences, Dr. Izsvák remarks.
However, due to mutations, the vast majority of the transposons became inactivated. Based on transposons in fish that are presumed to have been active approximately 20 million years ago, Dr. Ivics and Dr. Izsvák resurrected a jumping gene more than ten years ago. They named the transposon Sleeping Beauty, because they literally awakened it after a long evolutionary "sleep".
With their new tool, they were able to introduce genes into cells of vertebrates which was impossible before, as researchers previously lacked efficient transposon technologies to do so. However, the efficiency of the new transposon remained limited in some cells, such as stem cells.
Hundredfold Increase in Sleeping Beauty's Activity
The scientists solved this problem by slightly changing the genetic code of Sleeping Beauty, resulting in a hundredfold increase in its activity. Now, a transferred gene (transgene) finds its way into the cell's genome more easily. "Our hyperactive Sleeping Beauty is safer, easier, and cheaper than any other method before," says Dr. Izsvák.
Currently, scientists use disarmed viruses or a variety of non-virus based methods to get genes into cells. However, these methods are either too dangerous or too inefficient for broad application in gene therapy. Experiments with the new transposon system in mice showed that transgenes enter the genome safely and are stably integrated, says Dr. Ivics. Even after a year, the genes were still active.
The MDC researchers hope that their new tool is going to become the new standard method to introduce genes into cells. "Already this year, the first clinical trial with the transposon developed in our lab shall take place in the USA", says Dr. Ivics. According to him, Sleeping Beauty will be used to transport a therapeutic gene into isolated immune cells (T cells). These altered cells will then be used to treat a specific form of cancer (B-lymphoid malignancies) in patients.
The research is part of a project funded by the European Union and coordinated by the MDC. Together with nine partners from seven European countries, the MDC-researchers seek for novel, nonviral technologies for therapeutic gene delivery.
*Molecular Evolution of a Novel Hyperactive Sleeping Beauty Transposase Enables Robust Stable Gene Transfer in Vertebrates
Lajos Mátés1,*, Marinee K. L. Chuah2,*, Eyayu Belay2, Boris Jerchow1, Namitha Manoj1, Abel Acosta-Sanchez2, Dawid P. Grzela1, Andrea Schmitt1, Katja Becker1, Janka Matrai2, Ling Ma2, Esmira Samara-Kuko2, Cony Gysemans5, Diana Pryputniewicz1, Csaba Miskey1, Bradley Fletcher3, Thierry VandenDriessche2, Zoltán Ivics1 and Zsuzsanna Izsvák1,4
* Contributed equally
1 Max Delbrück Center for Molecular Medicine, Berlin, Germany
2 Flanders Institute for Biotechnology (VIB), Vesalius Research Center, University of Leuven, Leuven, Belgium
3 Department of Pharmacology and Therapeutics, University of Florida, College of Medicine, Gainesville, FL 32610-0267, USA.
4 Institute of Biochemistry, Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary
5 Department of Experimental Medicine, Laboratory for Experimental Transplantation, University of Leuven, Belgium
Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de
http://www.mdc-berlin.de/
http://www.mdc-berlin.de/en/news/2008/20080314-mdc_researchers_reconstruct_jumpi...
http://www.mdc-berlin.de/en/news/2006/20060308-molecular_invasion_-_sleeping_bea...
http://www2.mdc-berlin.de/izsvak/eng/pages/disclaimer.htm
Merkmale dieser Pressemitteilung:
Biologie, Chemie, Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
